Lack of efficacy of tacrolimus in the treatment of vitiligo in the absence of UV-B exposure [12]

Archives of Dermatology

Volumn 142, Issue 2, 2006, Pages 252-253

  Ostovari, Nima ^b   Passeron, Thierry ^a   Lacour, Jean Philippe ^b   Ortonne, Jean Paul ^b  

^a CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

TSUKUBAENOLIDE;

CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DRUG TOLERABILITY; ERYTHEMA; EXCIMER LASER; HUMAN; LETTER; MONOTHERAPY; PILOT STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIATION DOSE; RADIATION EXPOSURE; RADIATION PROTECTION; SCORING SYSTEM; SKIN PIGMENTATION; ULTRAVIOLET B RADIATION; VISUAL ANALOG SCALE; VITILIGO; WINTER;

FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; PROSPECTIVE STUDIES; TACROLIMUS; TREATMENT OUTCOME; ULTRAVIOLET RAYS; VITILIGO;

EID: 33244455903     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.142.2.252     Document Type: Letter

References (8)

1. Smith DA, Tofte SJ, Hanifin JM. Repigmentation of vitiligo with topical tacrolimus. Dermatology. 2002;205:301-303.
2. Grimes PE, Soriano T, Dytoc MT. Topical tacrolimus for repigmentation of vitiligo. J Am Acad Dermatol. 2002;47:789-791.
3. Travis LB, Weinberg JM, Silverberg NB. Successful treatment of vitiligo with 0.1% tacrolimus ointment. Arch Dermatol. 2003;139:571-574.
4. Lepe V, Moncada B, Castanedo-Cazares JP, Torres-Alvarez MB, Ortiz CA, Torres-Rubalcava AA. Double-blind randomized trial of 0.1% tacrolimus vs 0.05% clobetasol for the treatment of childhood vitiligo. Arch Dermatol. 2003;139:581-585.
5. Tanghetti EA. Tacrolimus ointment 0.1% produces repigmentation in patients with vitiligo: results of a prospective patient series. Cutis. 2003;71:158-162.
6. Passeron T, Ostovari N, Zakaria W, et al. Topical tacrolimus and the 308-nm excimer laser: a synergistic combination for the treatment of vitiligo. Arch Dermatol. 2004;140:1065-1069.
7. Kawalek AZ, Spencer JM, Phelps RG. Combined excimer laser and topical tacrolimus for the treatment of vitiligo: a pilot study. Dermatol Surg. 2004;30:130-135.
8. Westerhof W, Nieuweboer-Krobotova L, Mulder PG, Glazenburg EJ. Left-right comparison study of the combination of fluticasone propionate and UV-A vs either fluticasone propionate or UV-A alone for the long-term treatment of vitiligo. Arch Dermatol. 1999;135:1061-1066.